Haplotype analysis suggests that the two predominant mutations in Japanese patients with holocarboxylase synthetase deficiency are founder mutations.

Source:http://linkedlifedata.com/resource/pubmed/id/11185745

Download in:

View as

General Info

PMID
11185745